# Bioequivalence Study of Levocetirizine Dihydrochloride Tablets 5 mg Under Fed Condition

> **NCT01567501** · PHASE1 · COMPLETED · sponsor: **IPCA Laboratories Ltd.** · enrollment: 28 (actual)

## Conditions studied

- Fed

## Interventions

- **DRUG:** Levocetirizine Dihydrochloride tablets 5 mg
- **DRUG:** Levocetirizine Dihydrochloride

## Key facts

- **NCT ID:** NCT01567501
- **Lead sponsor:** IPCA Laboratories Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2012-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01567501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01567501, "Bioequivalence Study of Levocetirizine Dihydrochloride Tablets 5 mg Under Fed Condition". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01567501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*